End of Life
What is "end of life"?
The term “end of life” refers to the final stages of a person’s life, typically when they are facing a terminal illness or advanced age and are approaching death. A decline in health, increased vulnerability, and the anticipation of an imminent death characterize this phase. End-of-life care is a specialized form of medical and emotional support provided to individuals in this stage, with the primary goal of ensuring comfort, dignity, and the highest possible quality of life during their final days.
Ketamine-assisted therapy is a new therapy technique that combines ketamine with adjunct psychotherapy. Ketamine is used in end of life care as a pain management medication. However, recent research demonstrates that ketamine, in cohort with therapy, is an effective treatment for anxiety-related conditions such as end-of-life distress. Ketamine therapy’s enhancement of emotional processing, and induction of an altered state of consciousness may allow for the alleviation of end-of-life anxiety.
Psychotherapy, also known as talk therapy or counselling, is a well-established technique that has been an effective modality for a variety of mental health conditions. Therapy techniques may be effective in navigating end-of-life distress by helping people maintain dignity, meaning and peace as they approach the end of life. Dignity therapy and meaning-centered psychotherapy may be prudent techniques to help manage anxiety caused by end-of-life.
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive medical treatment that regulatory authorities have approved for the treatment of various neuropsychiatric conditions. Case study results suggest improvements in depression and anxiety symptoms throughout treatment. However, the literaturesurrounding rTMS for end-of-life care is mixed. It is important to discuss with your physician to see if this could be a viable treatment option.
Health Canada’s Special Access Program enables the use of certain psychedelic substances that are not marketed in Canada as requested by practitioners. Access is typically granted for treating, diagnosing, or preventing serious or life-threatening conditions when conventional therapies or medications have failed. End-of-life related anxiety falls under the category of serious or life-threatening conditions and has been shown to be an effective option for those transitioning through end-of-life. Psilocybin trials have been largely successful in reducing anxiety and depressive symptoms related to end-of-life distress.
If any of this strikes a chord for you or for a loved one, please take some time to reflect on these considerations before reaching out to us to book an Info Session. From there, we can support you in determining whether one of our treatments could be right for you, and how to begin your healing journey with Cena Life.